Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment.
Abstract | PURPOSE: EXPERIMENTAL DESIGN: RESULTS:
Nimbolide inhibited proliferation, induced apoptosis, and suppressed NF-κB activation and NF-κB-regulated tumorigenic proteins in colorectal cancer cells. The suppression of NF-κB activation by nimbolide was caused by sequential inhibition of IκB kinase (IKK) activation, IκBα phosphorylation, and p65 nuclear translocation. Furthermore, the effect of nimbolide on IKK activity was found to be direct. In vivo, nimbolide (at 5 and 20 mg/kg body weight), injected intraperitoneally after tumor inoculation, significantly decreased the volume of colorectal cancer xenografts. The limonoid-treated xenografts exhibited significant downregulation in the expression of proteins involved in tumor cell survival (Bcl-2, Bcl-xL, c-IAP-1, survivin, and Mcl-1), proliferation (c-Myc and cyclin D1), invasion (MMP-9, ICAM-1), metastasis (CXCR4), and angiogenesis ( VEGF). The limonoid was found to be bioavailable in the blood plasma and tumor tissues of treated mice. CONCLUSIONS: Our studies provide evidence that nimbolide can suppress the growth of human colorectal cancer through modulation of the proinflammatory microenvironment.
|
Authors | Subash C Gupta, Sahdeo Prasad, Dhanya R Sethumadhavan, Mangalam S Nair, Yin-Yuan Mo, Bharat B Aggarwal |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 19
Issue 16
Pg. 4465-76
(Aug 15 2013)
ISSN: 1557-3265 [Electronic] United States |
PMID | 23766363
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | ©2013 AACR. |
Chemical References |
- Antineoplastic Agents, Phytogenic
- Limonins
- NF-kappa B
- STAT3 Transcription Factor
- nimbolide
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(administration & dosage, pharmacokinetics, pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Colorectal Neoplasms
(drug therapy, genetics, pathology)
- Disease Models, Animal
- Enzyme Activation
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Limonins
(administration & dosage, pharmacokinetics, pharmacology)
- Mice
- NF-kappa B
(antagonists & inhibitors)
- STAT3 Transcription Factor
(metabolism)
- Tumor Burden
(drug effects)
- Tumor Microenvironment
(drug effects, genetics)
- Xenograft Model Antitumor Assays
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|